Key result
Pulsatile mechanical circulatory support improves vascular signaling over continuous flow, but renal benefits remain inconclusive.
Why the study?
Continuous-flow left ventricular assist devices alter normal pulsatile physiology, potentially affecting the arterial baroreflex, sympathetic nervous system, and nitric oxide release.
Does pulsatile flow mechanical circulatory support improve sympathetic regulation, nitric oxide bioavailability, and renal function compared to continuous flow in patients and models with heart failure?
Does pulsatile flow mechanical circulatory support improve sympathetic regulation, nitric oxide bioavailability, and renal function compared to continuous flow in patients and models with heart failure?
Answers are grounded in this paper and cite their sources.
Although pulsatile flow LVADs reduce sympathetic nerve activity and improve endothelial nitric oxide release compared to continuous flow devices, overall improvements in cardiac output with LVAD support appear to override these physiological benefits regarding clinical renal function outcomes.
Left ventricular assist devices have gained traction both as a bridge therapy and as a destination therapy in the management of heart failure. Many of these devices reinstate blood flow in a continuous manner as opposed to the pulsatile flow present in normal physiology. This loss of pulsatility can alter the arterial baroreflex and sympathetic nervous system as well as modify release of nitric oxide. This review focuses on the relationship between pulsatility and sympathetic nerve activity with an emphasis on how this may alter kidney function. Our findings indicate that, in the clinical context of ventricular dysfunction and mechanical circulatory support, pulsatile flow may lower levels of sympathetic nerve activity and theoretically improve nitric oxide function. While there are inhibitory effects on sympathetic nerve activity during pulsatile flow, the downstream effects on renal function remain inconclusive with the caveat that these studies are often underpowered retrospective observational studies that use indirect measures of renal function. We suggest that future studies need to incorporate more sensitive markers of tubular and glomerular function to establish if pulsatility indeed has positive outcomes on renal function. Based on current data, we speculate that the improvement in cardiac output and redistribution of blood flow within the kidney may override putative beneficial effects of altered pulsatility observed in experimental studies.
No takes yet. Share an insight, caveat, or question.
Warnakulasuriya et al. (2026) conducted a review in Heart failure managed with left ventricular assist devices (LVADs). Pulsatile flow left ventricular assist devices (LVADs) vs. Continuous flow left ventricular assist devices (LVADs) was evaluated on Sympathetic nerve activity, nitric oxide bioavailability, and renal function (eGFR, serum creatinine, creatinine clearance, and renal microcirculation). Pulsatile flow during mechanical circulatory support lowers sympathetic nerve activity and enhances nitric oxide release compared to continuous flow, though clinical effects on renal function remain inconclusive.
Synapse has enriched 10 related papers. Consider them for comparative context: